Temat: "Prostate-Specific Antigen" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK.
Autorzy:: Down L; Department of Health and Community Sciences, University of Exeter, St Lukes Campus, Heavitree Road, Exeter, EX1 2LU, UK. .
Barlow M; Department of Health and Community Sciences, University of Exeter, St Lukes Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Bailey SER; Department of Health and Community Sciences, University of Exeter, St Lukes Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Mounce LTA; Department of Health and Community Sciences, University of Exeter, St Lukes Campus, Heavitree Road, Exeter, EX1 2LU, UK.
Merriel SWD; Centre for Primary Care & Health Services Research, University of Manchester, Oxford Road, Manchester, M13 9PL, UK.
Watson J; Centre for Academic Primary Care (CAPC), Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
Martins T; Department of Health and Community Sciences, University of Exeter, St Lukes Campus, Heavitree Road, Exeter, EX1 2LU, UK.; Pokaż więcej
Źródło:: BMC medicine [BMC Med] 2024 Mar 01; Vol. 22 (1), pp. 82. Date of Electronic Publication: 2024 Mar 01.
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Male ; Humans ; Adult ; Middle Aged ; Cohort Studies ; Ethnicity ; Retrospective Studies ; Primary Health Care ; United Kingdom/epidemiology ; White

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study.
Autorzy:: Pinkeova A; Glycanostics, Ltd., Bratislava, Slovak Republic.; Institute of Chemistry, Bratislava, Slovak Republic.
Tomikova A; Glycanostics, Ltd., Bratislava, Slovak Republic.
Bertokova A; Glycanostics, Ltd., Bratislava, Slovak Republic.
Fabinyova E; Glycanostics, Ltd., Bratislava, Slovak Republic.
Bartova R; Glycanostics, Ltd., Bratislava, Slovak Republic.
Jane E; Glycanostics, Ltd., Bratislava, Slovak Republic.; Institute of Chemistry, Bratislava, Slovak Republic.
Hroncekova S; Institute of Chemistry, Bratislava, Slovak Republic.
Sievert KD; Klinikum Lippe - Clinic for Urology, Detmold, Germany.
Sokol R; Private Urological Ambulance, Trencin, Slovak Republic.
Jirasko M; Department of Pharmacology and Toxicology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.
Kucera R; Department of Pharmacology and Toxicology, Faculty of Medicine in Pilsen, Charles University, Pilsen, Czech Republic.; Department of Immunochemistry Diagnostics, University Hospital in Pilsen, Pilsen, Czech Republic.
Eder IE; Division of Experimental Urology, Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
Horninger W; Division of Experimental Urology, Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
Klocker H; Division of Experimental Urology, Department of Urology, Medical University Innsbruck, Innsbruck, Austria.
Ďubjaková P; University Hospital Bratislava, Bratislava, Slovakia.
Fillo J; University Hospital Bratislava, Bratislava, Slovakia.
Bertok T; Glycanostics, Ltd., Bratislava, Slovak Republic.; Institute of Chemistry, Bratislava, Slovak Republic.
Tkac J; Glycanostics, Ltd., Bratislava, Slovak Republic.; Institute of Chemistry, Bratislava, Slovak Republic.; Pokaż więcej
Źródło:: PloS one [PLoS One] 2024 Mar 18; Vol. 19 (3), pp. e0300430. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/pathology
Male ; Humans ; Biomarkers, Tumor ; Prostate/pathology ; ROC Curve ; Early Detection of Cancer ; Glycoproteins ; Polysaccharides

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A study on the impact of marital status on the survival status of prostate cancer patients based on propensity score matching.
Autorzy:: Chen Q; The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian, China.; The School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.
Zhu X; The School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.
Hu Y; The School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.; National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 100050, China.
Chen Y; The School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.
Dai R; The School of Public Health, Fujian Medical University, Fuzhou, 350108, Fujian, China.
Li J; Anyang University, Anyang, 455000, Henan, China.
Zhuang J; The School of Clinical Medicine, Fujian Medical University, Fuzhou, 350108, Fujian, China.
Lin Y; The School of Clinical Medicine, Fujian Medical University, Fuzhou, 350108, Fujian, China.
Zeng Y; Cyberspace Institute of Advanced Technology, Guangzhou University, Guangzhou, China.
You L; The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian, China.
Zeng Y; The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian, China. y_.
Huang Q; The Second Affiliated Hospital of Fujian Medical University, Quanzhou, 362000, Fujian, China. q_.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 14; Vol. 14 (1), pp. 6162. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*
Male ; Humans ; Propensity Score ; SEER Program ; Marital Status ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Mortality reduction and cumulative excess incidence (CEI) in the prostate-specific antigen (PSA) screening era.
Autorzy:: McLaughlin PW; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.; Department of Radiation Oncology, Assarian Cancer Center, Ascension Providence Hospital, Novi, MI, USA.
Cousins MM; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA. .; Department of Advanced Radiation Oncology, Self Regional Healthcare, Greenwood, SC, USA. .
Tsodikov A; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI, USA.
Soni PD; Department of Radiation Oncology, Dignity Health Cancer Institute, Phoenix, AZ, USA.
Crook JM; British Columbia Cancer Agency and University of British Columbia, Kelowna, BC, Canada.; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2024 Mar 09; Vol. 14 (1), pp. 5810. Date of Electronic Publication: 2024 Mar 09.
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Male ; Humans ; United States/epidemiology ; Incidence ; Early Detection of Cancer ; Mass Screening/methods

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Progression-directed therapy in patients with oligoprogressive castration-resistant prostate cancer.
Autorzy:: Lee JN; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim MY; Department of Radiation Oncology, Kyungpook National University Chilgok Hospital, Daegu, Korea.
Kang JH; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kang JK; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Chung JW; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Ha YS; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Choi SH; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim BS; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim HT; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim TH; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Yoo ES; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kim SH; Department of Radiology, School of Medicine, Kyungpook National University, Daegu, Korea.
Kwon TG; Department of Urology, School of Medicine, Kyungpook National University, Daegu, Korea. .; Pokaż więcej
Źródło:: Investigative and clinical urology [Investig Clin Urol] 2024 Mar; Vol. 65 (2), pp. 132-138.
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms, Castration-Resistant*/drug therapy
Prostatic Neoplasms, Castration-Resistant*/pathology
Male ; Humans ; Retrospective Studies ; Treatment Outcome ; Progression-Free Survival

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: New Molecular Markers for Prostate Cancer Diagnosis.
Autorzy:: Amiri M; Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. .
Asadi Samani L; Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. .
Kashi AH; Urology and Nephrology Research Center, Shahid Labbafinejad Medical Center, Shahid Beheshti University, Tehran, Iran. .
Khadem N; Department of Cardiovascular, Faculty of Medicine, Urmia University of Medical Science, Urmia, Iran. .
Ziaee SAM; Urology and Nephrology Research Center, Shahid Labbafinejad Medical Center, Shahid Beheshti University, Tehran, Iran. .
Mowla SJ; Department of Molecular Genetics, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran. .; Pokaż więcej
Źródło:: Urology journal [Urol J] 2024 Feb 28; Vol. 21 (1), pp. 1-13. Date of Electronic Publication: 2024 Feb 28.
Typ publikacji:: Review; Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/genetics
Prostatic Neoplasms*/pathology
Male ; Humans ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/urine ; Antigens, Neoplasm/genetics ; Antigens, Neoplasm/urine ; RNA

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Ki67 and prostate specific antigen are prognostic in metastatic hormone naïve prostate cancer.
Autorzy:: Spyratou V; Department of Urology, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.
Freyhult E; Department of Cell and Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
Bergh A; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Thellenberg-Karlsson C; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Wikström P; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Welén K; Department of Urology, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.; Sahlgrenska Center for Cancer Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
Josefsson A; Department of Urology, Institute of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå, Sweden.; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden.; Pokaż więcej
Źródło:: Acta oncologica (Stockholm, Sweden) [Acta Oncol] 2023 Dec; Vol. 62 (12), pp. 1698-1706. Date of Electronic Publication: 2023 Sep 15.
Typ publikacji:: Journal Article
MeSH Terms:: Ki-67 Antigen*
Prostate-Specific Antigen*
Prostatic Neoplasms*/drug therapy
Prostatic Neoplasms*/pathology
Humans ; Male ; Androgen Antagonists/therapeutic use ; Androgens/therapeutic use ; Docetaxel/adverse effects ; Prognosis

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: SARIFA as a new histopathological biomarker is associated with adverse clinicopathological characteristics, tumor-promoting fatty-acid metabolism, and might predict a metastatic pattern in pT3a prostate cancer.
Autorzy:: Enke JS; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Groß M; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Grosser B; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Sipos E; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Steinestel J; Urology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Löhr P; Hematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Waidhauser J; Hematology and Oncology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Lapa C; Nuclear Medicine, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Märkl B; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany.
Reitsam NG; Pathology, Faculty of Medicine, University of Augsburg, Augsburg, Germany. .; Pokaż więcej
Źródło:: BMC cancer [BMC Cancer] 2024 Jan 12; Vol. 24 (1), pp. 65. Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/pathology
Male ; Humans ; Positron Emission Tomography Computed Tomography ; Disease-Free Survival ; Prostatectomy/methods ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Comparison of Nuclear Medicine Therapeutics Targeting PSMA among Alpha-Emitting Nuclides.
Autorzy:: Kaneda-Nakashima K; Laboratory of Radiation Biological Chemistry, FRC, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.; MS-CORE, FRC, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.; Department of Science, Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.
Shirakami Y; MS-CORE, FRC, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.; Department of Science, Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.
Kadonaga Y; MS-CORE, FRC, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.; Nuclear Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Watabe T; MS-CORE, FRC, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.; Nuclear Medicine, Graduate School of Medicine, Osaka University, Suita 565-0871, Japan.
Ooe K; MS-CORE, FRC, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.; Radioisotope Research Center, Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.
Yin X; Nishina Center for Accelerator-Based Science Nuclear Chemistry Group, RIKEN, Wako 351-0198, Japan.
Haba H; Nishina Center for Accelerator-Based Science Nuclear Chemistry Group, RIKEN, Wako 351-0198, Japan.
Shirasaki K; Laboratory of Alpha-Ray Emitters, Institute for Materials Research, Tohoku University, Sendai 980-8577, Japan.
Kikunaga H; Research Center for Electron Photon Science, Tohoku University, Sendai 982-0826, Japan.
Tsukada K; Research Group of Heavy Element Nuclear Science, Advanced Science Research Center, Japan Atomic Energy Agency, Naka-gun 319-1195, Japan.
Toyoshima A; MS-CORE, FRC, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.; Department of Science, Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.
Cardinale J; Nuclear Medicine Department, University Hospital Düsseldorf, 40225 Düsseldorf, Germany.
Giesel FL; Nuclear Medicine Department, University Hospital Düsseldorf, 40225 Düsseldorf, Germany.
Fukase K; MS-CORE, FRC, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.; Department of Science, Institute for Radiation Sciences, Osaka University, Suita 565-0871, Japan.; Natural Product Chemistry, Graduate School of Science, Osaka University, Toyonaka 560-0043, Japan.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 11; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 11.
Typ publikacji:: Journal Article
MeSH Terms:: Prostatic Neoplasms*/drug therapy
Radioisotopes*/therapeutic use
Prostate-Specific Antigen*
Humans ; Male ; Half-Life ; Nuclear Medicine

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Preoperative Factors for Lymphovascular Invasion in Prostate Cancer: A Systematic Review and Meta-Analysis.
Autorzy:: Karwacki J; University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Stodolak M; University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Nowak Ł; University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Kiełb P; University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Krajewski W; University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Lemiński A; Department of Urology and Urological Oncology, Pomeranian Medical University, 70-111 Szczecin, Poland.
Szydełko T; University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Małkiewicz B; University Center of Excellence in Urology, Department of Minimally Invasive and Robotic Urology, Wroclaw Medical University, 50-556 Wroclaw, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2024 Jan 10; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article; Review
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/surgery
Male ; Humans ; Retrospective Studies ; Biopsy ; Clinical Decision-Making

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Metabolomic profiles of intact tissues reflect clinically relevant prostate cancer subtypes.
Autorzy:: Dudka I; Department of Chemistry, Umeå University, Umeå, Sweden.
Lundquist K; Department of Chemistry, Umeå University, Umeå, Sweden.
Wikström P; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden. .
Bergh A; Department of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Gröbner G; Department of Chemistry, Umeå University, Umeå, Sweden. .; Pokaż więcej
Źródło:: Journal of translational medicine [J Transl Med] 2023 Nov 27; Vol. 21 (1), pp. 860. Date of Electronic Publication: 2023 Nov 27.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/pathology
Male ; Humans ; Ki-67 Antigen/metabolism ; Magnetic Resonance Spectroscopy ; Magnetic Resonance Imaging ; Metabolomics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Economic evaluation of prostate cancer risk assessment methods: A cost-effectiveness analysis using population data.
Autorzy:: Mohammadi T; Centre for Advancing Health Outcomes (formerly Centre for Health Evaluation and Outcome Sciences), Providence Health Care Research Institute, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Guh DP; Centre for Advancing Health Outcomes (formerly Centre for Health Evaluation and Outcome Sciences), Providence Health Care Research Institute, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Tam ACT; Centre for Advancing Health Outcomes (formerly Centre for Health Evaluation and Outcome Sciences), Providence Health Care Research Institute, St. Paul's Hospital, Vancouver, British Columbia, Canada.
Pataky RE; Canadian Centre for Applied Research in Cancer Control, BC Cancer, Vancouver, British Columbia, Canada.
Black PC; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
So A; Department of Urologic Sciences, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
Lynd LD; Centre for Advancing Health Outcomes (formerly Centre for Health Evaluation and Outcome Sciences), Providence Health Care Research Institute, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Zhang W; Centre for Advancing Health Outcomes (formerly Centre for Health Evaluation and Outcome Sciences), Providence Health Care Research Institute, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.
Conklin AI; Centre for Advancing Health Outcomes (formerly Centre for Health Evaluation and Outcome Sciences), Providence Health Care Research Institute, St. Paul's Hospital, Vancouver, British Columbia, Canada.; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada.; Pokaż więcej
Źródło:: Cancer medicine [Cancer Med] 2023 Oct; Vol. 12 (19), pp. 20106-20118. Date of Electronic Publication: 2023 Sep 23.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Prostatic Neoplasms*/epidemiology
Male ; Humans ; Cost-Benefit Analysis ; Cost-Effectiveness Analysis ; Risk Assessment

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Prostate-specific antigen screening for prostate cancer: An old but never-ending story.
Autorzy:: Kim SI; Department of Urology, Ajou University School of Medicine, Suwon, Korea. .; Pokaż więcej
Źródło:: Investigative and clinical urology [Investig Clin Urol] 2023 Sep; Vol. 64 (5), pp. 422-424.
Typ publikacji:: Editorial; Comment
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Male ; Humans ; Early Detection of Cancer

Opinia redakcyjna

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: The Transcriptomic Profiles of ESR1 and MMP3 Stratify the Risk of Biochemical Recurrence in Primary Prostate Cancer beyond Clinical Features.
Autorzy:: Olczak M; II Clinic of Urology, Medical University of Lodz, Pabianicka 62, 93-513 Lodz, Poland.
Orzechowska MJ; Department of Molecular Carcinogenesis, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Lodz, Poland.
Bednarek AK; Department of Molecular Carcinogenesis, Medical University of Lodz, Żeligowskiego 7/9, 90-752 Lodz, Poland.
Lipiński M; II Clinic of Urology, Medical University of Lodz, Pabianicka 62, 93-513 Lodz, Poland.; Pokaż więcej
Źródło:: International journal of molecular sciences [Int J Mol Sci] 2023 May 07; Vol. 24 (9). Date of Electronic Publication: 2023 May 07.
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*/genetics
Prostatic Neoplasms*/pathology
Humans ; Male ; Matrix Metalloproteinase 3 ; Neoplasm Grading ; Neoplasm Recurrence, Local/pathology ; Prostatectomy ; Retrospective Studies ; Transcriptome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Phage Display's Prospects for Early Diagnosis of Prostate Cancer.
Autorzy:: Petrenko VA; Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA.; Pokaż więcej
Źródło:: Viruses [Viruses] 2024 Feb 10; Vol. 16 (2). Date of Electronic Publication: 2024 Feb 10.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Bacteriophages*
Prostatic Neoplasms*/diagnosis
Male ; Humans ; Prostate-Specific Antigen ; Quality of Life ; Early Detection of Cancer

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Impact of PSA testing on secondary care costs in England and Wales: estimates from the Cluster randomised triAl of PSA testing for Prostate cancer (CAP).
Autorzy:: Thorn JC; Bristol Medical School, Population Health Sciences, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK. .
Turner EL; Bristol Medical School, Population Health Sciences, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
Walsh EI; Bristol Medical School, Population Health Sciences, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
Donovan JL; Bristol Medical School, Population Health Sciences, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
Neal DE; Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Hamdy FC; Nuffield Department of Surgical Sciences, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
Martin RM; Bristol Medical School, Population Health Sciences, University of Bristol, Canynge Hall, 39 Whatley Road, Bristol, BS8 2PS, UK.
Noble SM; Bristol Medical School, Population Health Sciences, 1-5 Whiteladies Road, Bristol, BS8 1NU, UK.; Pokaż więcej
Źródło:: BMC health services research [BMC Health Serv Res] 2023 Jun 09; Vol. 23 (1), pp. 610. Date of Electronic Publication: 2023 Jun 09.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnosis
Male ; Humans ; Wales ; Secondary Care ; Mass Screening ; England

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: A prospective comparative study of [ Ga]Ga-PSMA-617 PET/CT imaging in suspicious prostate cancer.
Autorzy:: Gao X; Department of Pathology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China.
Tang Y; Department of Nuclear Medicine, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China.
Chen M; Department of Urology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China.
Li J; Department of Nuclear Medicine, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China.
Yin H; Department of Pathology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China.
Gan Y; Department of Urology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China.
Zu X; Department of Urology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China. .
Cai Y; Department of Urology, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China. .
Hu S; Department of Nuclear Medicine, Disorders of Prostate Cancer Multidisciplinary Team, National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China. .; Key Laboratory of Biological, Nanotechnology of National Health Commission, Xiangya Hospital, Central South University, Hunan Province, No.87 Xiangya Road, Changsha City, 410008, People's Republic of China. .; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 Jun; Vol. 50 (7), pp. 2177-2187. Date of Electronic Publication: 2023 Feb 22.
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Male ; Humans ; Positron Emission Tomography Computed Tomography/methods ; Prospective Studies ; Gallium Radioisotopes

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Long-Term Oncological Outcomes for Histologically Confirmed High-Risk Prostate Cancer.
Autorzy:: Takeda H; Department of Urology, Nippon Medical School.
Akatsuka J; Department of Urology, Nippon Medical School.
Yuki E; Department of Urology, Nippon Medical School.
Matsuzawa I; Department of Urology, Nippon Medical School.
Suzuki Y; Department of Urology, Nippon Medical School.; Department of Urology, Nippon Medical School Chiba Hokusoh Hospital.
Hamasaki T; Department of Urology, Nippon Medical School Musashi Kosugi Hospital.
Kimura G; Department of Urology, Nippon Medical School.
Kondo Y; Department of Urology, Nippon Medical School.; Pokaż więcej
Źródło:: Journal of Nippon Medical School = Nippon Ika Daigaku zasshi [J Nippon Med Sch] 2023 May 30; Vol. 90 (2), pp. 202-209. Date of Electronic Publication: 2023 Feb 21.
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms*/surgery
Prostatic Neoplasms*/pathology
Male ; Humans ; Retrospective Studies ; Neoplasm Grading ; Risk Factors ; Prostatectomy/methods ; Neoplasm Recurrence, Local/surgery ; Treatment Outcome ; Disease-Free Survival

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Extended therapy with [ Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer.
Autorzy:: Mader N; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Nguyen Ngoc C; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Kirkgöze B; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Baumgarten J; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Groener D; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Klimek K; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Happel C; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Tselis N; Department of Radiation Oncology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Chun FKH; Department of Urology, University Hospital Frankfurt, Frankfurt am Main, Germany.
Grünwald F; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany.
Sabet A; Department of Nuclear Medicine, University Hospital Frankfurt, Frankfurt am Main, Germany. .; Pokaż więcej
Źródło:: European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2023 May; Vol. 50 (6), pp. 1811-1821. Date of Electronic Publication: 2023 Jan 27.
Typ publikacji:: Journal Article
MeSH Terms:: Prostate-Specific Antigen*
Prostatic Neoplasms, Castration-Resistant*/radiotherapy
Male ; Humans ; Treatment Outcome ; Positron Emission Tomography Computed Tomography ; Neoplasm, Residual/chemically induced ; Dipeptides/adverse effects ; Heterocyclic Compounds, 1-Ring/adverse effects ; Lutetium/therapeutic use ; Retrospective Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Transperineal Laser Ablation (TPLA) Treatment of Focal Low–Intermediate Risk Prostate Cancer.
Autorzy:: Manenti, Gugliemo (AUTHOR)
Perretta, Tommaso (AUTHOR)
Nezzo, Marco (AUTHOR)
Fraioli, Federico Romeo (AUTHOR)
Carreri, Beatrice (AUTHOR)
Gigliotti, Paola Elda (AUTHOR)
Micillo, Andrea (AUTHOR)
Malizia, Andrea (AUTHOR)
Di Giovanni, Daniele (AUTHOR)
Ryan, Colleen Patricia (AUTHOR)
Garaci, Francesco Giuseppe (AUTHOR); Pokaż więcej
Źródło:: Cancers. Apr2024, Vol. 16 Issue 7, p1404. 14p.

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Prostate-Specific Antigen"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język

Rok publikacji